Detalles de la búsqueda
1.
Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer.
Gynecol Oncol
; 138(1): 18-23, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925990
2.
Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation.
Eur J Cancer
; 70: 146-155, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27817944
3.
Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial.
Target Oncol
; 10(2): 255-65, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25195590
Resultados
1 -
3
de 3
1
Próxima >
>>